GALT - Galectin Therapeutics, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts3223
Avg. Estimate-0.11-0.13-0.53-0.48
Low Estimate-0.12-0.17-0.53-0.6
High Estimate-0.11-0.09-0.52-0.35
Year Ago EPS-0.12-0.15-0.76-0.53
Revenue EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts3233
Avg. EstimateN/AN/AN/A3.33M
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/A10M
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History12/30/20163/30/20176/29/20179/29/2017
EPS Est.-0.17-0.16-0.15-0.14
EPS Actual-0.12-0.15-0.14-0.13
Difference0.050.010.010.01
Surprise %29.40%6.30%6.70%7.10%
EPS TrendCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Current Estimate-0.11-0.13-0.53-0.48
7 Days Ago-0.11-0.13-0.53-0.48
30 Days Ago-0.11-0.13-0.53-0.48
60 Days Ago-0.11-0.13-0.53-0.48
90 Days Ago-0.12-0.17-0.53-0.47
EPS RevisionsCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesGALTIndustrySectorS&P 500
Current Qtr.8.30%N/AN/A0.34
Next Qtr.13.30%N/AN/A0.40
Current Year30.30%N/AN/A0.17
Next Year9.40%N/AN/A0.11
Next 5 Years (per annum)N/AN/AN/A0.12
Past 5 Years (per annum)N/AN/AN/AN/A